Health News

Clevertouch Marketing named Martech Enabled Execution Agency of the Year in B2B Marketing 2020 Martech Awards

The prestigious award recognises the very best talent, achievement and success in the B2B martech arena Hampshire, UK, April 14, 2020 – Clevertouch Marketing, Europe’s most respected marketing technology consulting and service provider, has been named Martech Enabled Execution Agency of the Year in B2B Marketing 2020 Martech Awards for transforming the landscape and possibilities… Read More: Clevertouch Marketing named Martech Enabled Execution Agency of the Year… »

Coronavirus: Don’t expect changes to UK lockdown this week – Dominic Raab

The government does not expect to make changes to coronavirus lockdown restrictions this week, Dominic Raab has said. The foreign secretary said the UK’s plan “is working” but that “we are still not past the peak of this virus”. “Keep this up, we have come too far, lost too many loved ones and sacrificed too… Read More: Coronavirus: Don’t expect changes to UK lockdown this week –… »

What you need to know today about the virus outbreak

The coronavirus pandemic has thrown millions out of work and devastated economies worldwide, and governments are struggling with the delicate balance between keeping people safe from a highly contagious virus and making sure they can still make a living or even have enough to eat. The United States’ top infectious disease expert, Dr. Anthony Fauci,… Read More: What you need to know today about the virus outbreak »

FiercePharmaAsia—Takeda-CSL coronavirus tie-up; Qiming’s $1B VC fund; Fujifilm’s Avigan COVID-19 trial

Takeda has formed a multinational alliance to work on an unbranded hyperimmune globulin therapy for COVID-19. China’s Qiming Venture Partners, which previously backed CanSino Bio and Zai Lab, has set up another venture fund. Following some encouraging early evidence and the initiation of a Japanese study, Fujifilm will test influenza med Avigan in a U.S.… Read More: FiercePharmaAsia—Takeda-CSL coronavirus tie-up; Qiming’s $1B VC fund; Fujifilm’s Avigan COVID-19… »